WRITE: Written Communication in the ICU

Sponsor
Rush University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05636371
Collaborator
(none)
200
1
1
9
22.3

Study Details

Study Description

Brief Summary

The goal of this study is to compare the experience of intensive care unit (ICU) families and care providers before and after the implementation of an approach whereby clinicians initiate written communication with families

The main questions it aims to answer are

  1. Is ICU care-provider initiated written communication feasible and acceptable to participants?

  2. Does ICU care-provider initiated written communication affect the experience of families and care providers?

Participants will complete surveys and participate in interviews during a 3 month pre-implementation phase and a 3 month post-implementation phase

Condition or Disease Intervention/Treatment Phase
  • Other: Written Communication
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Impact of WRitten Communication on the ICU Team Experience
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Written Communication

ICU care providers will initiate the process for providing written communication to families. Study investigators will facilitate the creation and distribution of written communication

Other: Written Communication
Written patient care updates provided to families of ICU patients each day

Outcome Measures

Primary Outcome Measures

  1. Family Inpatient Communication Survey (FICS) [5 days after ICU admission]

    The Family Inpatient Communication Survey (FICS) is a 30-item survey measuring of the quality of communication with the treatment team from the perspective of families of hospitalized patients. Items on this survey measure the informational and emotional aspects of communication, and each item of this survey is rated on a 5-point Likert scale from strongly agree to strongly disagree. The FICS has been validated in a study of 350 surrogates of hospitalized adults demonstrating the high internal reliability, predictive validity, and high item completion rates of this survey.

  2. Family Inpatient Communication Survey (FICS) [10 days after ICU admission]

    The Family Inpatient Communication Survey (FICS) is a 30-item survey measuring of the quality of communication with the treatment team from the perspective of families of hospitalized patients. Items on this survey measure the informational and emotional aspects of communication, and each item of this survey is rated on a 5-point Likert scale from strongly agree to strongly disagree. The FICS has been validated in a study of 350 surrogates of hospitalized adults demonstrating the high internal reliability, predictive validity, and high item completion rates of this survey.

  3. Nurse-Physician Collaboration Scale (NPCS) [3 months before the intervention]

    The Nurse-Physician Collaboration Scale (NPCS) is a 27-item survey measuring the level of collaboration between nurses and physicians based on three categories: joint participation in the decision-making process, the sharing of patient information, and cooperativeness.Items on this survey are rated on a 5-point scale with responses ranging from always to never. The NPCS has been validated in a study of 446 physicians and 1217 nurses at 27 hospitals.

  4. Nurse-Physician Collaboration Scale (NPCS) [3 months after the intervention]

    The Nurse-Physician Collaboration Scale (NPCS) is a 27-item survey measuring the level of collaboration between nurses and physicians based on three categories: joint participation in the decision-making process, the sharing of patient information, and cooperativeness.Items on this survey are rated on a 5-point scale with responses ranging from always to never. The NPCS has been validated in a study of 446 physicians and 1217 nurses at 27 hospitals.

  5. Maslach Burnout Inventory (MBI) [3 months before the intervention]

    The Maslach Burnout Inventory (MBI) is a 22-item survey measuring symptoms of burnout. The MBI has been validated for a variety of professions. The MBI has been used in past studies in the ICU to evaluate the level of burnout present among critical care clinicians and to assess for the effectiveness of interventions attempting to alleviate the degree of burnout syndrome. This survey examines the participant's perception of their work, physical and emotional exhaustion, sense of personal accomplishment, and degree of depersonalization. Items are presented as single statements, such as "I feel worn out at the end of a working day," and are rated on a scale of 0 to 6 with 0 being "never" and 6 being "every day."

  6. Maslach Burnout Inventory (MBI) [3 months after the intervention]

    The Maslach Burnout Inventory (MBI) is a 22-item survey measuring symptoms of burnout. The MBI has been validated for a variety of professions. The MBI has been used in past studies in the ICU to evaluate the level of burnout present among critical care clinicians and to assess for the effectiveness of interventions attempting to alleviate the degree of burnout syndrome. This survey examines the participant's perception of their work, physical and emotional exhaustion, sense of personal accomplishment, and degree of depersonalization. Items are presented as single statements, such as "I feel worn out at the end of a working day," and are rated on a scale of 0 to 6 with 0 being "never" and 6 being "every day."

Secondary Outcome Measures

  1. The Acceptability, Appropriateness and Feasibility of Intervention Survey (AIM, IAM and FIM) [3 months after the intervention]

    Care providers will complete this 12-item psychometric assessment. Implementation science researchers have established the benchmarks and acceptance of this scale.

  2. The Post Study System Usability Questionnaire (PSSUQ) [3 months after the intervention]

    The Post Study System Usability Questionnaire (PSSUQ) is a 16-item PSSUQ survey that measures the acceptance of new technology. PSSUQ measures perception of information quality, interface quality, and overall intervention usefulness. Lewis et al have published on the high internal validity and sensitivity of this scale since 1992.

  3. The User Experience Questionnaire (UEQ) [3 months after the intervention]

    The User Experience Questionnaire (UEQ) is a 26-item scale to measure the overall user experience of the family member(s) who used the communication intervention. The UEQ measures user experience on items including attractiveness, perspicuity, efficiency, dependability, stimulation, and novelty. UEQ has high internal validity and has been benchmarked across numerous usability and user experience evaluation studies.

Other Outcome Measures

  1. Qualitative analysis [3 months after the intervention]

    Semi-structured interviews with participants will be coded and examined using thematic content analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion criteria (family members or surrogates)

• Self-identify as one of the patient's decision makers

Exclusion criteria (family members or surrogates)

  • Cannot read or understand English

  • Unwilling to participate in study procedures

Inclusion criteria for care providers (physicians, physician assistants, and nurses)

• Work during the day shift

Exclusion criteria for care providers (physicians, physician assistants, and nurses)

• None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rush University Medical Center Chicago Illinois United States 60612

Sponsors and Collaborators

  • Rush University Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT05636371
Other Study ID Numbers:
  • 22092704-IRB01
First Posted:
Dec 5, 2022
Last Update Posted:
Dec 5, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 5, 2022